Top

Archives of Gynecology and Obstetrics

Published in:

01-03-2013 | General Gynecology

Premenstrual syndrome: a single-blind study of treatment with buspirone versus fluoxetine

Authors: Hedayat Nazari, Fatemeh Yari, Mojgan Jariani, Atefeh Marzban, Mahdi Birgandy

Published in: Archives of Gynecology and Obstetrics | Issue 3/2013

Abstract

Purpose

The premenstrual syndrome (PMS), which causes emotional and physical symptoms, is a common problem in many women in their reproductive age. Many approaches to PMS with controversial results are available. The present study was performed to compare fluoxetine and buspirone in the treatment of PMS.

Methods

One hundred female patients who met DSM-IV criteria for PMS were randomly divided into two groups in a single-blind study; one group was treated with fluoxetine 20 mg/day and the other group with buspirone 10 mg/day for two consecutive months. The subjects were evaluated in pretreatment, after 1 and 2 months of treatment with a valid and reliable questionnaire.

Results

Both fluoxetine and buspirone showed significant efficacy in the treatment of PMS and this efficacy was significant along the treatment period. However, no significant differences were observed between fluoxetine and buspirone in the treatment of PMS.

Conclusion

Considering efficacy and few side effects of buspirone, it can be a favorable drug in the treatment of patients with PMS. However, further studies (preferably double-blind, placebo controlled ones) with large sample sizes are recommended to investigate efficacy and side effects of buspirone.

Wyatt K, Dimmock P, Jones P, Obhrai M, O’Brien S (2001) Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review. BMJ 323:776PubMedCrossRef

Adrianne B (2000) The potential for dietary supplements to reduce premenstrual syndrome (PMS) symptoms. Am Coll Nutr 19:3–12

Slade P (1984) Premenstrual emotional changes in normal women: fact or fiction. J Psychosom Res 28:245–264CrossRef

Cronje WH, Vashisht A, Studd JWW (2004) Hysterectomy and bilateral oophorectomy for severe premenstrual syndrome. Hum Reprod Embryol 19:2152–2155CrossRef

Steiner M, Brown E, Trzepacz P, Dillon J, Berger C, Carter D, Reid R, Stewart D (2003) Fluoxetine improves functional work capacity in women with premenstrual dysphonic disorder. Arch Women Men Health 6:71–77CrossRef

Jacobs ST, McMahon D, John P (2007) Bilezikian differences in free estradiol and sex hormone-binding globulin in women with and without premenstrual dysphonic disorder. J Clin Endocrinol Metab 93:96–102CrossRef

Halbreich U (2008) Selective serotonin reuptake inhibitors and initial oral contraceptives for the treatment of PMDD: effective but not enough. CNS Spectr 13:566–572PubMed

Bertone-Johnson ER, Hankinson SE, Bendich A, Johnson SR, Willett WC, Manson JE (2005) Calcium and vitamin D intake and risk of incident premenstrual syndrome. Arch Intern Med 165:1246–1252PubMedCrossRef

Wyatt KM, Dimmock PW, Frischer M, Jones PW, O’Brien SP (2002) Prescribing patterns in premenstrual syndrome. BMC Women Health 19:2–4

10.

Daugherty JE (1998) Treatment strategies for premenstrual syndrome. Am Fam Physician 58:183–192PubMed

11.

Habek D, Habek JC, Barbir A (2002) Using acupuncture to treat premenstrual syndrome. Arch Gynecol Obstet 267:23–26PubMedCrossRef

12.

Eriksson E, Hedberg MA, Andersch B, Sundblad C (1995) The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology 12:167–176PubMedCrossRef

13.

Krasnik C, Montori VM, Guyatt GH, Heels-Ansdell D, Busse JW (2005) The effect of bright light therapy on depression associated with premenstrual dysphoric disorder. Am J Obstet Gynecol 193:658–661PubMedCrossRef

14.

Rapkin AJ (2005) New treatment approaches for premenstrual disorder. Am J Manag Care 11:S480–S491PubMed

15.

Lustyk MK, Widman L, Paschane A, Ecker E (2004) Stress, quality of life and physical activity in women with varying degrees of premenstrual symptomatology. Women Health 39:35–44PubMedCrossRef

16.

Jarvis CI, Lynch AM, Morin AK (2008) Management strategies for premenstrual syndrome/premenstrual dysphoric disorder. Ann Pharmacother 42:967–978PubMedCrossRef

17.

Romano S, Judge R, Dillon J, Shuler C, Sundell (1999) The role of fluoxetine in the treatment of premenstrual dysphoric disorder. Clin Ther 21:615–633PubMedCrossRef

18.

Landen M, Erikson O, Sundblad C, Anderson B, Naessen T, Erikson E (2001) Compounds with affinity for serotonergic receptors in the treatment of premenstrual dysphoria. Psychopharmacology (Berl) 155:292–298CrossRef

19.

Roca CA, Schmidt PJ, Altemus M, Deuster P, Danaceau MA, Putnam K, Rubinow DR (2003) Differential menstrual cycle regulation of hypothalamic-pituitary-adrenal axis in women with premenstrual syndrome and controls. J Clin Endocrinol Metab 88:3057–3063PubMedCrossRef

20.

Ozeren S, Corakçi A, Yücesoy I, Mercan R, Erhan G (1997) Fluoxetine in the treatment of premenstrual syndrome. Eur J Obstet Gynecol Reprod Biol 73(2):167–170PubMedCrossRef

21.

Su TP, Schmidt PJ, Danaceau MA, Tobin MB, Rosenstein DL, Murphy DL, Rubinow DR (1997) Fluoxetine in the treatment of premenstrual dysphoria. Neuropsychopharmacology 16:346–356PubMedCrossRef

22.

Shah NR, Jones JB, Aperi J, Shemtov R, Karne A, Borenstein J (2008) Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis. Obstet Gynecol 111:1175–1182PubMedCrossRef

23.

Wu KY, Liu CY, Hsiao MC (2008) Six-month paroxetine treatment of premenstrual dysphoric disorder: continuous versus intermittent treatment protocols. Psychiatry Clin Neurosci 62:109–114PubMedCrossRef

Title: Premenstrual syndrome: a single-blind study of treatment with buspirone versus fluoxetine
Authors: Hedayat Nazari
Fatemeh Yari
Mojgan Jariani
Atefeh Marzban
Mahdi Birgandy
Publication date: 01-03-2013
Publisher: Springer-Verlag
Published in: Archives of Gynecology and Obstetrics / Issue 3/2013
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-012-2594-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Premenstrual syndrome: a single-blind study of treatment with buspirone versus fluoxetine

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2013

Intramural ectopic pregnancy with live birth at 37 weeks of gestation

Erratum to: A case with vesicouterine fistula: mini review

Minimal invasive approaches for large ovarian cysts: a careful choice

Sequential clomiphene citrate/hMG versus hMG for ovulation induction in clomiphene citrate-resistant women

Unexpected malignancies after laparoscopic-assisted supracervical hysterectomies (LASH): an analysis of 1,584 LASH cases

Elucidation of regulatory mechanisms revealed by human promoter sequence analysis of genes co-expressed in forskolin-treated theca cells in PCOS